Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes
Maria A Christou1, Panagiota A Christou1, Christos Kyriakopoulos2
1Department of Endocrinology, University of Ioannina Faculty of Medicine, 45500 Ioannina, Greece.
Abstract:
Hypoglycemia is common in patients with type 1 and type 2 diabetes (T1D, T2D), treated with insulin or sulfonylureas, and has multiple short- and long-term clinical implications. Whether acute or recurrent, hypoglycemia significantly affects the cardiovascular system with the potential to cause cardiovascular dysfunction. Several pathophysiological mechanisms have been proposed linking hypoglycemia to increased cardiovascular risk, including hemodynamic changes, myocardial ischemia, abnormal cardiac repolarization, cardiac arrhythmias, prothrombotic and proinflammatory effects, and induction of oxidative stress. Hypoglycemia-induced changes can promote the development of endothelial dysfunction, which is an early marker of atherosclerosis. Although data from clinical trials and real-world studies suggest an association between hypoglycemia and cardiovascular events in patients with diabetes, it remains uncertain whether this association is causal. New therapeutic agents for patients with T2D do not cause hypoglycemia and have cardioprotective benefits, whereas increasing the use of new technologies, such as continuous glucose monitoring devices and insulin pumps, has the potential to reduce hypoglycemia and its adverse cardiovascular outcomes in patients with T1D.
Insights
Hypoglycemia, common in diabetes patients, can harm the cardiovascular system. New diabetes treatments and technologies may reduce these risks, improving patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Hypoglycemia is a frequent complication for individuals with type 1 and type 2 diabetes (T1D, T2D).
- It is associated with significant short- and long-term clinical implications, particularly affecting the cardiovascular system.
- Existing treatments like insulin and sulfonylureas increase hypoglycemia risk.
Purpose of the Study:
- To explore the pathophysiological mechanisms linking hypoglycemia to cardiovascular risk in diabetic patients.
- To evaluate the association between hypoglycemia and cardiovascular events.
- To discuss the potential of new therapeutic agents and technologies in mitigating these risks.
Main Methods:
- Review of proposed pathophysiological mechanisms.
- Analysis of clinical trial and real-world data.
- Discussion of emerging technologies and therapeutic strategies.
Main Results:
- Hypoglycemia can lead to cardiovascular dysfunction through various mechanisms including hemodynamic changes, myocardial ischemia, arrhythmias, and oxidative stress.
- Hypoglycemia-induced changes may promote endothelial dysfunction and atherosclerosis.
- While studies suggest an association between hypoglycemia and cardiovascular events, causality remains uncertain.
Conclusions:
- Hypoglycemia poses a significant cardiovascular risk for diabetes patients.
- Newer diabetes medications for T2D offer cardioprotective benefits without causing hypoglycemia.
- Continuous glucose monitoring and insulin pumps may reduce hypoglycemia and associated cardiovascular risks in T1D.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational


